Affymax Inc Com (NASDAQOTH:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

0
Player Avatar Imhilion (25.32) Submitted: 2/25/2013 1:14:29 PM : Outperform Start Price: $2.39 AFFY Score: +39.84

I have a theory that the polysorbate 20 found in Omontys is what's triggering the anaphylaxis symptoms. If so it's a simple matter of switching the ingredient out to keep it viable

http://www.ncbi.nlm.nih.gov/pubmed/16400901

Bought IRL at $2.36

Featured Broker Partners


Advertisement